Talanx AG
Talanx AG (TLLXY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Talanx AG (TLLXY), covering cash flow, earnings, and balance sheets.
Talanx AG (TLLXY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Talanx AG TLLXY financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11.96B | -$13.06B | $24.08B | $15.65B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $2.41B |
| Gross Profit | $11.96B | -$13.06B | $24.08B | $13.24B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.85 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $11.54B | -$14.24B | $24.08B | $14.35B |
| Total Costs & Expenses | $11.54B | -$14.24B | $24.08B | $14.35B |
| Interest Income | $0.00 | $70.00M | $0.00 | $4.00M |
| Interest Expense | $54.00M | $107.00M | $54.00M | $58.00M |
| Depreciation & Amortization | $0.00 | -$52.00M | $0.00 | $0.00 |
| EBITDA | $1.27B | $1.24B | $566.00M | $0.00 |
| EBITDA Ratio | $0.11 | -$0.09 | $0.02 | $0.00 |
| Operating Income | $1.27B | $1.18B | $566.00M | $1.30B |
| Operating Income Ratio | $0.11 | -$0.09 | $0.02 | $0.08 |
| Other Income/Expenses (Net) | -$54.00M | -$2.00M | $582.00M | -$58.00M |
| Income Before Tax | $1.22B | $1.18B | $1.11B | $1.24B |
| Income Before Tax Ratio | $0.10 | -$0.09 | $0.05 | $0.08 |
| Income Tax Expense | $344.00M | $501.00M | $209.00M | $363.00M |
| Net Income | $604.00M | $385.00M | $502.00M | $518.00M |
| Net Income Ratio | $0.05 | -$0.03 | $0.02 | $0.03 |
| EPS | $2.34 | $1.49 | $1.95 | $2.01 |
| Diluted EPS | $2.34 | $1.49 | $1.95 | $2.01 |
| Weighted Avg Shares Outstanding | $258.23M | $257.61M | $257.61M | $258.23M |
| Weighted Avg Shares Outstanding (Diluted) | $258.23M | $257.61M | $257.61M | $258.23M |
Over the past four quarters, Talanx AG demonstrated steady revenue growth, increasing from $15.65B in Q2 2024 to $11.96B in Q1 2025. Operating income reached $1.27B in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.27B, reflecting operational efficiency. Net income rose to $604.00M, with EPS at $2.34. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan